スポンサーリンク
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Japan | 論文
- Establishment and Validation of a Rabbit Model for In Vivo Pharmacodynamic Screening of Tachykinin NK_2 Antagonists
- Effects of TAK-480, a Novel Tachykinin NK2–Receptor Antagonist, on Visceral Hypersensitivity in Rabbits and Ricinoleic Acid–Induced Defecation in Guinea Pigs
- Effects of TAK-480, a Novel Tachykinin NK_2-Receptor Antagonist, on Visceral Hypersensitivity in Rabbits and Ricinoleic Acid-Induced Defecation in Guinea Pigs